UPDATE: Alkermes (ALKS) Tops Q2 EPS by 18c (CORRECTION)

(Updated - July 28, 2021 11:14 AM EDT)

Alkermes (NASDAQ: ALKS) reported Q2 EPS of $0.30, $0.18 better than the analyst estimate of $0.12. Revenue for the quarter came in at $303.7 million versus the consensus estimate of $278.7 million.

GUIDANCE:

Alkermes sees FY2021 EPS of $0.52-$0.70, versus the consensus of $0.51. Alkermes sees FY2021 revenue of $1.145-1.185 billion, versus the consensus of $1.14 billion.

For earnings history and earnings-related data on Alkermes (ALKS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance
• Minerals Technologies (MTX) Tops Q1 EPS by 16c